Docking and scoring: applications to drug discovery in the interactomics era

Background: Computational approaches such as docking and scoring are becoming routine in drug discovery as a complement to other more traditional techniques. However, so far, computer drug design methods have been applied to inhibit the function of individual proteins, and there is little available...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Expert opinion on drug discovery 2009-06, Vol.4 (6), p.673-686
Hauptverfasser: Grosdidier, Solène, Fernández-Recio, Juan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 686
container_issue 6
container_start_page 673
container_title Expert opinion on drug discovery
container_volume 4
creator Grosdidier, Solène
Fernández-Recio, Juan
description Background: Computational approaches such as docking and scoring are becoming routine in drug discovery as a complement to other more traditional techniques. However, so far, computer drug design methods have been applied to inhibit the function of individual proteins, and there is little available data on the use of these computational techniques to target protein-protein interactions. Objective: To establish a strategy for the use of current computational tools in drug discovery targeting protein-protein interactions. Method: Individual techniques applied to specific cases could be studied to derive a general strategy for targeting protein-protein interactions. Conclusion: Protein docking, interface prediction and hot-spot identification can contribute to the discovery of small molecule inhibitors targeting protein interactions of therapeutic interest, especially when little structural information is available.
doi_str_mv 10.1517/17460440903002067
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_23489159</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1317835832</sourcerecordid><originalsourceid>FETCH-LOGICAL-c406t-c3215e179e15cc3b89e1bb239326f006a59b3b19c33dafc44a98ca4215a2e5903</originalsourceid><addsrcrecordid>eNp9UMtKBDEQDKL4WP0AL5Kjl9FkksxDvcj6hAUvCt5CTybjRmeSNcko-_dGVgURPHXRXVVUF0L7lBxRQctjWvKCcE5qwgjJSVGuoe3PXUa4eFz_wZxuoZ0QngkRrGJsE23ljFc1FfU2ml049WLsEwbb4qCcT_gEw2LRGwXROBtwdLj14xNuTbq_ab_ExuI412lE7UFFNxgVcIK7aKODPui9rzlBD1eX99ObbHZ3fTs9n2WKkyJmiuVUaFrWmgqlWFMl0DQ5q1ledIQUIOqGNbRWjLXQKc6hrhTwJIJci_TsBB2ufBfevY46RDmkbLrvwWo3BkkZLSsmKpYnKl1RlXcheN3JhTcD-KWkRH6WKP-UmDQHX_ZjM-j2R_HdWiKcrQjGds4P8O5838oIy975zoNVJkj2n__pL_lcQx_nCryWz270NlX3T7oPJ6qRPw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1317835832</pqid></control><display><type>article</type><title>Docking and scoring: applications to drug discovery in the interactomics era</title><source>Taylor &amp; Francis Medical Library - CRKN</source><source>Taylor &amp; Francis Journals Complete</source><creator>Grosdidier, Solène ; Fernández-Recio, Juan</creator><creatorcontrib>Grosdidier, Solène ; Fernández-Recio, Juan</creatorcontrib><description>Background: Computational approaches such as docking and scoring are becoming routine in drug discovery as a complement to other more traditional techniques. However, so far, computer drug design methods have been applied to inhibit the function of individual proteins, and there is little available data on the use of these computational techniques to target protein-protein interactions. Objective: To establish a strategy for the use of current computational tools in drug discovery targeting protein-protein interactions. Method: Individual techniques applied to specific cases could be studied to derive a general strategy for targeting protein-protein interactions. Conclusion: Protein docking, interface prediction and hot-spot identification can contribute to the discovery of small molecule inhibitors targeting protein interactions of therapeutic interest, especially when little structural information is available.</description><identifier>ISSN: 1746-0441</identifier><identifier>EISSN: 1746-045X</identifier><identifier>DOI: 10.1517/17460440903002067</identifier><identifier>PMID: 23489159</identifier><language>eng</language><publisher>England: Informa UK Ltd</publisher><subject>hot-spots ; protein-protein docking ; protein-protein interactions ; virtual ligand screening</subject><ispartof>Expert opinion on drug discovery, 2009-06, Vol.4 (6), p.673-686</ispartof><rights>Informa UK Ltd 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c406t-c3215e179e15cc3b89e1bb239326f006a59b3b19c33dafc44a98ca4215a2e5903</citedby><cites>FETCH-LOGICAL-c406t-c3215e179e15cc3b89e1bb239326f006a59b3b19c33dafc44a98ca4215a2e5903</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.1517/17460440903002067$$EPDF$$P50$$Ginformaworld$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.1517/17460440903002067$$EHTML$$P50$$Ginformaworld$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,59647,59753,60436,60542</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23489159$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Grosdidier, Solène</creatorcontrib><creatorcontrib>Fernández-Recio, Juan</creatorcontrib><title>Docking and scoring: applications to drug discovery in the interactomics era</title><title>Expert opinion on drug discovery</title><addtitle>Expert Opin Drug Discov</addtitle><description>Background: Computational approaches such as docking and scoring are becoming routine in drug discovery as a complement to other more traditional techniques. However, so far, computer drug design methods have been applied to inhibit the function of individual proteins, and there is little available data on the use of these computational techniques to target protein-protein interactions. Objective: To establish a strategy for the use of current computational tools in drug discovery targeting protein-protein interactions. Method: Individual techniques applied to specific cases could be studied to derive a general strategy for targeting protein-protein interactions. Conclusion: Protein docking, interface prediction and hot-spot identification can contribute to the discovery of small molecule inhibitors targeting protein interactions of therapeutic interest, especially when little structural information is available.</description><subject>hot-spots</subject><subject>protein-protein docking</subject><subject>protein-protein interactions</subject><subject>virtual ligand screening</subject><issn>1746-0441</issn><issn>1746-045X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNp9UMtKBDEQDKL4WP0AL5Kjl9FkksxDvcj6hAUvCt5CTybjRmeSNcko-_dGVgURPHXRXVVUF0L7lBxRQctjWvKCcE5qwgjJSVGuoe3PXUa4eFz_wZxuoZ0QngkRrGJsE23ljFc1FfU2ml049WLsEwbb4qCcT_gEw2LRGwXROBtwdLj14xNuTbq_ab_ExuI412lE7UFFNxgVcIK7aKODPui9rzlBD1eX99ObbHZ3fTs9n2WKkyJmiuVUaFrWmgqlWFMl0DQ5q1ledIQUIOqGNbRWjLXQKc6hrhTwJIJci_TsBB2ufBfevY46RDmkbLrvwWo3BkkZLSsmKpYnKl1RlXcheN3JhTcD-KWkRH6WKP-UmDQHX_ZjM-j2R_HdWiKcrQjGds4P8O5838oIy975zoNVJkj2n__pL_lcQx_nCryWz270NlX3T7oPJ6qRPw</recordid><startdate>20090601</startdate><enddate>20090601</enddate><creator>Grosdidier, Solène</creator><creator>Fernández-Recio, Juan</creator><general>Informa UK Ltd</general><general>Taylor &amp; Francis</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20090601</creationdate><title>Docking and scoring: applications to drug discovery in the interactomics era</title><author>Grosdidier, Solène ; Fernández-Recio, Juan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c406t-c3215e179e15cc3b89e1bb239326f006a59b3b19c33dafc44a98ca4215a2e5903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>hot-spots</topic><topic>protein-protein docking</topic><topic>protein-protein interactions</topic><topic>virtual ligand screening</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Grosdidier, Solène</creatorcontrib><creatorcontrib>Fernández-Recio, Juan</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Expert opinion on drug discovery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Grosdidier, Solène</au><au>Fernández-Recio, Juan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Docking and scoring: applications to drug discovery in the interactomics era</atitle><jtitle>Expert opinion on drug discovery</jtitle><addtitle>Expert Opin Drug Discov</addtitle><date>2009-06-01</date><risdate>2009</risdate><volume>4</volume><issue>6</issue><spage>673</spage><epage>686</epage><pages>673-686</pages><issn>1746-0441</issn><eissn>1746-045X</eissn><abstract>Background: Computational approaches such as docking and scoring are becoming routine in drug discovery as a complement to other more traditional techniques. However, so far, computer drug design methods have been applied to inhibit the function of individual proteins, and there is little available data on the use of these computational techniques to target protein-protein interactions. Objective: To establish a strategy for the use of current computational tools in drug discovery targeting protein-protein interactions. Method: Individual techniques applied to specific cases could be studied to derive a general strategy for targeting protein-protein interactions. Conclusion: Protein docking, interface prediction and hot-spot identification can contribute to the discovery of small molecule inhibitors targeting protein interactions of therapeutic interest, especially when little structural information is available.</abstract><cop>England</cop><pub>Informa UK Ltd</pub><pmid>23489159</pmid><doi>10.1517/17460440903002067</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1746-0441
ispartof Expert opinion on drug discovery, 2009-06, Vol.4 (6), p.673-686
issn 1746-0441
1746-045X
language eng
recordid cdi_pubmed_primary_23489159
source Taylor & Francis Medical Library - CRKN; Taylor & Francis Journals Complete
subjects hot-spots
protein-protein docking
protein-protein interactions
virtual ligand screening
title Docking and scoring: applications to drug discovery in the interactomics era
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T12%3A58%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Docking%20and%20scoring:%20applications%20to%20drug%20discovery%20in%20the%20interactomics%20era&rft.jtitle=Expert%20opinion%20on%20drug%20discovery&rft.au=Grosdidier,%20Sol%C3%A8ne&rft.date=2009-06-01&rft.volume=4&rft.issue=6&rft.spage=673&rft.epage=686&rft.pages=673-686&rft.issn=1746-0441&rft.eissn=1746-045X&rft_id=info:doi/10.1517/17460440903002067&rft_dat=%3Cproquest_pubme%3E1317835832%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1317835832&rft_id=info:pmid/23489159&rfr_iscdi=true